Official Newsletter of the Utah Poison Control Center 2010 • VOLUME 12 • ISSUE 4 T O D A Y NEW DRUGS FOR TREATMENT OF DIABETES - Tipranavir - Document - PDFSEARCH.IO

First Page		Document Content
Date: 2016-06-02 15:25:44 Dipeptidyl peptidase-4 inhibitors Eli Lilly and Company Amides Anti-diabetic drugs Peptide hormones Exenatide Anti-diabetic medication Sitagliptin Saxagliptin Metformin Glucagon-like peptide-1 agonist Sulfonylurea		Official Newsletter of the Utah Poison Control Center 2010 • VOLUME 12 • ISSUE 4 T O D A Y NEW DRUGS FOR TREATMENT OF DIABETES Add to Reading List Source URL: poisoncontrol.utah.edu Download Document from Source Website File Size: 1,00 MB Share Document on Facebook

	C:uments and Settingsyandktoprmacists Bulletin July 2015.wpd DocID: 1qQog - View Document
	SPECIAL AUTHORIZATION REQUEST DPP-4/SGLT2 INHIBITORS Fax requests toOR mail requests to PEI Pharmacare, P.O. Box 2000, Charlottetown, PE, C1A 7N8 SECTION 1 – PRESCRIBER INFORMATION DocID: 1pr3h - View Document
	Official Newsletter of the Utah Poison Control Center 2010 • VOLUME 12 • ISSUE 4 T O D A Y NEW DRUGS FOR TREATMENT OF DIABETES DocID: 1oY1K - View Document
	g iF F5t+ Erlft [9.tr Et [+ Govemo da Regiio AdministrativaEspecialde Macau 6i+.tr DocID: 17KbB - View Document
	Monthly briefings are produced in order to help members of the media and other interested people understand the work and advice of the Scottish Medicines Consortium. The detailed advice for each medicine that DocID: 177OZ - View Document